Correlation Between XORTX Therapeutics and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both XORTX Therapeutics and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XORTX Therapeutics and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XORTX Therapeutics and Cue Biopharma, you can compare the effects of market volatilities on XORTX Therapeutics and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XORTX Therapeutics with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of XORTX Therapeutics and Cue Biopharma.
Diversification Opportunities for XORTX Therapeutics and Cue Biopharma
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between XORTX and Cue is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding XORTX Therapeutics and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and XORTX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XORTX Therapeutics are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of XORTX Therapeutics i.e., XORTX Therapeutics and Cue Biopharma go up and down completely randomly.
Pair Corralation between XORTX Therapeutics and Cue Biopharma
Given the investment horizon of 90 days XORTX Therapeutics is expected to generate 1.38 times more return on investment than Cue Biopharma. However, XORTX Therapeutics is 1.38 times more volatile than Cue Biopharma. It trades about 0.02 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.01 per unit of risk. If you would invest 230.00 in XORTX Therapeutics on September 2, 2024 and sell it today you would lose (103.00) from holding XORTX Therapeutics or give up 44.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
XORTX Therapeutics vs. Cue Biopharma
Performance |
| Timeline |
| XORTX Therapeutics |
| Cue Biopharma |
XORTX Therapeutics and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with XORTX Therapeutics and Cue Biopharma
The main advantage of trading using opposite XORTX Therapeutics and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XORTX Therapeutics position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| XORTX Therapeutics vs. Context Therapeutics | XORTX Therapeutics vs. Neurosense Therapeutics | XORTX Therapeutics vs. Quoin Pharmaceuticals Ltd | XORTX Therapeutics vs. Ensysce Biosciences |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |